SCHEMBL979435

SCHEMBL979435

O=C(Nc1cccc(-c2ccc(Oc3ccccc3)cc2)c1)c1cc2cccc(OC(F)(F)F)c2oc1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.49
MAOB P27338 5/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
ALDH1A1 P00352 1/20 0.47
GLA P06280 1/20 0.47
TP53 P04637 1/20 0.47
MAPT P10636 1/20 0.47
BRAF P15056 1/20 0.45
GALK1 P51570 1/20 0.45
CASP6 P55212 1/20 0.45
MCL1 Q07820 1/20 0.45
PLEC Q15149 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
KCNK3 O14649 1/20 0.45
KCNK9 Q9NPC2 1/20 0.45
SCN8A Q9UQD0 1/20 0.44
SCN10A Q9Y5Y9 1/20 0.44
RXFP1 Q9HBX9 2/20 0.44
PNLIP P16233 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL982818 0.88 CASP3 (0.62) CASP3MAOBNPC1RAB9AALDH1A1
SCHEMBL982010 0.88 ALDH1A1 (0.54) CASP3MAOBNPC1RAB9AALDH1A1
SCHEMBL978791 0.87 RAB9A (0.55) CASP3MAOBNPC1RAB9ATP53
SCHEMBL981428 0.86 ALDH1A1 (0.53) CASP3MAOBNPC1RAB9AALDH1A1
SCHEMBL977891 0.86 AKR1C3 (0.54) CASP3MAOBNPC1RAB9AGALK1
SCHEMBL978431 0.83 CASP3 (0.47) CASP3MAOBNPC1RAB9AALDH1A1
SCHEMBL980389 0.82 CASP3 (0.53) CASP3MAOBNPC1RAB9ATP53
SCHEMBL979709 0.82 CASP3 (0.53) CASP3MAOBNPC1RAB9ATP53
SCHEMBL982817 0.81 CASP3 (0.61) CASP3MAOBNPC1RAB9AALDH1A1
SCHEMBL978098 0.81 ALDH1A1 (0.55) CASP3NPC1RAB9AALDH1A1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110021522-A1 ACTIVATORS OF EXECUTIONER PROCASPASES 3, 6 AND 7 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021522-A1 ACTIVATORS OF EXECUTIONER PROCASPASES 3, 6 AND 7 CASP7, CASP3, CASP6 CASP3 2/4885MAOB 3235/4885NPC1 2565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.